Scholarlink

Background <p>The global prevalence of vaginal candidiasis and group B streptococcus (GBS) colonization among pregnant women is significant and these pathogens are associated with adverse maternal and neonatal outcomes, including preterm birth, stillbirth, and neonatal infections.</p> Objective <p>This study aimed to determine the magnitude and risk factors for vaginal <i>Candida</i> and GBS in pregnant women who were attending antenatal care at Hawassa University Compressive Specialized Hospital from July October 2021.</p> Method <p>A Hospital-based, cross-sectional study was conducted using microscopy, culture, germ tube, and biochemical tests on vaginal swab samples from 110 volunteer pregnant women. A structured questionnaire was used to collect data on perceived risk factors. Data was analyzed using SPSS version 22, and an odds ratio at a 95% confidence interval with <i>p</i> &lt; 0.05 was used to interpret the risk factors.</p> Results <p><i>Candida</i> species was identified in 33 (30%) pregnant women, whereas, GBS colonization was not detected in any of them. Of the vaginal <i>Candida</i> species, 17 (51.52%) were <i>Candida albicans</i> and 16 (48.48%) were non-albicans <i>Candida</i>. Symptomatic vaginal candidiasis was diagnosed in only four women. The most important predictors of vaginal <i>Candida</i> colonization were parity of two and underwear replacement once a day.</p> Conclusion <p>Based on these findings, screening for vaginal candidiasis and prophylactic treatment should be considered for young, multiparous, pregnant women in their third trimester, if supported clinically.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The prevalence and risk factors of vaginal Candida species and group B Streptococcus colonization in pregnant women attending antenatal care at Hawassa university comprehensive specialized hospital in Hawassa City, Southern Ethiopia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月17日

查看全文
  • Atenaf Eskezia,
  • Abraham Mikru Teklemichael,
  • Tsegaye Alemayehu

摘要

Background

The global prevalence of vaginal candidiasis and group B streptococcus (GBS) colonization among pregnant women is significant and these pathogens are associated with adverse maternal and neonatal outcomes, including preterm birth, stillbirth, and neonatal infections.

Objective

This study aimed to determine the magnitude and risk factors for vaginal Candida and GBS in pregnant women who were attending antenatal care at Hawassa University Compressive Specialized Hospital from July October 2021.

Method

A Hospital-based, cross-sectional study was conducted using microscopy, culture, germ tube, and biochemical tests on vaginal swab samples from 110 volunteer pregnant women. A structured questionnaire was used to collect data on perceived risk factors. Data was analyzed using SPSS version 22, and an odds ratio at a 95% confidence interval with p < 0.05 was used to interpret the risk factors.

Results

Candida species was identified in 33 (30%) pregnant women, whereas, GBS colonization was not detected in any of them. Of the vaginal Candida species, 17 (51.52%) were Candida albicans and 16 (48.48%) were non-albicans Candida. Symptomatic vaginal candidiasis was diagnosed in only four women. The most important predictors of vaginal Candida colonization were parity of two and underwear replacement once a day.

Conclusion

Based on these findings, screening for vaginal candidiasis and prophylactic treatment should be considered for young, multiparous, pregnant women in their third trimester, if supported clinically.